Early Trial Results Show Promise For Johnson & Johnson And Beth Israel Vaccine
Excerpt from the Article:
Researchers have reported hopeful results from an early clinical trial of a potential coronavirus vaccine developed by a team from from Beth Israel Deaconess Medical Center and Johnson & Johnson. The company announced earlier this week it has moved forward to field test what could be a the first single-shot vaccine for the virus in a third and final phase clinical trial.
The completion of the early phase clinical trial suggested the vaccine is safe and may provide protection against COVID-19, according to the researchers.
Click the button below to continue reading the Article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?